[Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis]

Arch Pediatr. 2011 Nov;18(11):1201-4. doi: 10.1016/j.arcped.2011.08.011. Epub 2011 Oct 2.
[Article in French]

Abstract

We describe 3 cases of chronic purpuric skin lesions in children suffering from systemic vasculitis: 3 children with Henoch-Schönlein purpura. Dapsone was introduced when skin lesions were recurrent, extensive, and persistent, due to its known ability to act as an anti-IgA and as an anticytotoxic agent against polynuclear neutrophils. Fast and complete but purely suspensive healing of skin lesions was noted. One child developed methemoglobinemia, a known side-effect of dapsone, highlighting the need for adequate prescription and follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Dapsone / therapeutic use*
  • Female
  • Humans
  • IgA Vasculitis / complications*
  • Male
  • Skin Diseases / drug therapy*
  • Skin Diseases / etiology*

Substances

  • Dapsone